Looking for equity investors: B2B SaaS in Pharma and Life Sciences

I am signing LOI with a Prague based B2B SaaS company.

~40 clients primarily in pharma and life science industries globally (mostly EU, growing in India, some of them big names).

Modular product loved by users, 50% implementation time and cost vs. competition.

Impressive TAM with solid organic growth. Potential to expand regionally and into new industries (FMCG, Energy)

$1.6m ARR, +30% p.a., $700k EBITDA. Low churn.

Price ~3x multiple. Seller financing available.

Seeking equity investors who could help with expansion, primarily in the US, EU and India.

DM if interested for more details.